<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Einstein (Sao Paulo)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Einstein (Sao Paulo)</journal-id>
      <journal-title-group>
        <journal-title>Einstein</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1679-4508</issn>
      <issn pub-type="epub">2317-6385</issn>
      <publisher>
        <publisher-name>Instituto Israelita de Ensino e Pesquisa Albert Einstein</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25167337</article-id>
      <article-id pub-id-type="pmc">4872950</article-id>
      <article-id pub-id-type="publisher-id">S1679-45082014RC2953</article-id>
      <article-id pub-id-type="doi">10.1590/S1679-45082014RC2953</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>
<italic>Hypericum perforatum</italic>-induced hepatotoxicity with possible association with copaiba (<italic>Copaifera langsdorffii Desf</italic>):case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Agollo</surname>
            <given-names>Marjorie Costa</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miszputen</surname>
            <given-names>Sender Jankiel</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Diament</surname>
            <given-names>Jayme</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Escola Paulista de Medicina, Universidade Federal de S&#xE3;o Paulo, S&#xE3;o Paulo, SP, Brazil.</aff>
      <aff id="aff2"><label>2</label>Hospital Israelita Albert Einstein, S&#xE3;o Paulo, SP, Brazil.</aff>
      <author-notes>
        <corresp> Corresponding author: Sender Jankiel Miszputen &#x2212; Escola Paulista de Medicina, Universidade Federal de S&#xE3;o Paulo, Discipline of Gastroenterology, Rua Botucat&#xFA;, 740 &#x2212; Vila Clementino &#x2013; Zip code:04023-900 &#x2212; S&#xE3;o Paulo, SP, Brazil &#x2013; Phone: (55 11) 3825-1014 &#x2212; E-mail: <email>sender.miszputen@unifesp.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jul-Sep</season>
        <year>2014</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jul-Sep</season>
        <year>2014</year>
      </pub-date>
      <volume>12</volume>
      <issue>3</issue>
      <fpage>355</fpage>
      <lpage>357</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>8</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>12</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This work is licensed under a Creative Commons Attribution 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We report a case of liver damage in an elderly patient after the use of herbal products of <italic>Hypericum perforatum</italic> and <italic>copaiba</italic> (<italic>Copaifera langsdorffii Desf</italic>). Hepatotoxicity related to <italic>Hypericum perforatum</italic> is anecdotally known, but for copaiba, widely used as anti-inflammatory, there is just experimental data in the national literature. This report aimed to draw attention to the possible toxic effects of this association as well as to the clinical recovery of the patient after discontinuing their use. There is a tendency to suspect of the action of drugs to justify a non-viral acute liver injury, because of the large number of drugs responsible for hepatotoxicity. There are experiments and clinical reports in the literature describing some herbal products, including <italic>Hypericum perforatum</italic>, as the causative agents of this aggression, and are considered innocuous and used with no restrictions. We must remember that adverse reactions also occur with these substances; hence, they should be investigated when collecting the patient&#xB4;s history, for leading to severe liver failure.</p>
      </abstract>
      <kwd-group>
        <kwd>Drug-induced liver injury</kwd>
        <kwd><italic>Hypericum</italic>/adverse effects</kwd>
        <kwd>Phytotherapeutic drugs/adverse effects</kwd>
        <kwd>Case reports</kwd>
      </kwd-group>
      <counts>
        <fig-count count="0"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="14"/>
        <page-count count="3"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>The liver metabolizes many medications and is therefore subject to drug-induced toxicity. Hepatotoxicity occurs due to direct action in case of tuberculostatic agents,<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup> statins and paracetamol,<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> or it may be idiosyncratic and unexpected; it is an important clinical problem that may trigger liver failure, with fatal consequences, or patients may require urgent liver transplant.</p>
      <p>The incidence of hepatotoxicity is considered underestimated since the use of some drugs is often omitted. It manifests as acute or chronic liver failure and represents the single cause in up to 30% of acute hepatitis, or it appears as cholestasis, steatosis or fibrosis. Over 900 exogenous substances with hepatotoxic potential have been identified and there are also reports of herbaceous plants that can cause harm.<sup>(<xref rid="B3" ref-type="bibr">3</xref>)-<xref rid="B6" ref-type="bibr">6</xref>)</sup>
</p>
      <p>Men use a large amount of foods, medications and dietary supplements derived from plants. Kennedy and Wightman<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup> revised the mechanisms of action of different phytotherapeutic agents: alkaloids (caffeine and nicotine), terpenes (ginkgo, ginseng, valerian and <italic>Melissa officinalis</italic>) and phenolic compounds (curcumin, isoflavone and <italic>Hypericum perforatum</italic>).</p>
      <p>The acute clinical picture varies from no symptoms and abnormal laboratory findings found by chance to nausea, vomiting, abdominal pain, jaundice and acute hepatic failure, and it can overlap with preexisting liver diseases. The lesions are classified as hepatocellular, cholestatic, mixed or vascular. It is essential to ask about the use of medications to make diagnosis since there is no gold standard test, specific serum marker or histological profile to identify the cause of hepatic aggression.</p>
      <p>Treatment consists of discontinuation of the suspected product, general precautions, relative rest and bland diet, in addition to monitoring liver function due to risk of progressing to hepatic failure.<sup>(<xref rid="B8" ref-type="bibr">8</xref>)</sup>
</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 79-year-old female patient sought care for presenting jaundice for one month. Past history of hypothyroidism. She was on <italic>Hypericum</italic>
<italic>perforatum</italic>, copaiba, levothyroxine, omega 3, glucosamine and chondroitin. Upon physical examination, she was afebrile, normal blood pressure, with jaundice and tachycardia (100 bpm). Flacid abdomen, not painful upon palpation, no enlarged organs or signs of chronic liver disease. The laboratory tests revealed abnormal enzyme levels and hyperbilirubinemia, and other parameters were unaltered. Serology for viral hepatites and autoantibodies were negative. Magnetic resonance cholangiography showed no abnormalities.</p>
      <p>Treatment prescribed was rest and withdrawing all medications, except hormone replacement for thyroid.</p>
      <p>Among the laboratory tests that were initially increased, ALT-GPT dropped from 1,667U/L to 36U/L, and AST-GOT from 1,599U/L to 30U/L, after approximately 7 weeks. Similar recovery was observed in total bilirubin levels, that reduced from 9.0mg/dL to 1.24mg/dL, due to drop in the direct bilirubin fractions from 8.3mg/dL to 0.73mg/dL.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>
<italic>Hypericum perforatum</italic>, or St John&#xB4;s wort, is broadly distributed in many countries and indicated for treatment of mild to moderate depression,<sup>(<xref rid="B9" ref-type="bibr">9</xref>)</sup> anxiety, insomnia and nevralgia, and its antiviral, antibacterial and photosensitizing activities are well known. There is no consensus about its antidepressant action,<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup> but in some countries, including Germany, it represents roughly 25% of all prescriptions of this drug class, and it is available in compounding pharmacies, and phytotherapeutic and natural product shops.</p>
      <p>Acting on cytochrome P450, it might reduce the serum levels of some drugs or increase their clearance.<sup>(<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B5" ref-type="bibr">5</xref>)</sup> The interaction with other drugs favors its adverse effects,<sup>(<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>)</sup> including hepatotoxicity, as already mentioned.<sup>(<xref rid="B13" ref-type="bibr">13</xref>)</sup>
</p>
      <p>In the case presented, it was crucial to investigate other causes of acute hepatic disease, such as serology for hepatitis A, B and C viruses; autoimmunity despite her age, evaluated by the initial measurement of serum globulins; as well as imaging methods, particularly magnetic resonance cholangiography to exclude abnormalities in the intrahepatic and extrahepatic biliary ducts.</p>
      <p>The laboratory follow-up of the patient showed progressive drop in enzyme and bilirubin levels, after discontinuing the drugs suspected of being hepatotoxic, and the tests returned to normal levels with no intercurrent events.</p>
      <p>The second herbaceous product &#x2013; copaiba &#x2013; is an oil-resin extracted from the trunk of <italic>Copaifera ssp</italic>., and is often used in the Brazilian Northern and Northeastern regions as an anti-inflammatory agent. Its hepatotoxic effect is subject to discussion<sup>(<xref rid="B14" ref-type="bibr">14</xref>)</sup> and its participation, together with another phytotherapeutic drug, is not excluded in triggering the described medication-induced acute hepatitis.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malla</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Fauda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Casanueva</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fern&#xE1;ndez</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Amante</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cheang</surname>
              <given-names>Y</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Fulminant hepatic failure due to tuberculostatic drugs: case report</article-title>
          <source>Arch Argent Pediatr</source>
          <year>2012</year>
          <volume>110</volume>
          <issue>3</issue>
          <fpage>e35</fpage>
          <lpage>e38</lpage>
          <pub-id pub-id-type="pmid">22760756</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O&#x2019;Neil</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Hanlon</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Marcum</surname>
              <given-names>ZA</given-names>
            </name>
          </person-group>
          <article-title>Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics</article-title>
          <source>Am J Geriatr Pharmacother</source>
          <year>2012</year>
          <volume>10</volume>
          <issue>6</issue>
          <fpage>331</fpage>
          <lpage>342</lpage>
          <pub-id pub-id-type="pmid">23036838</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amorim</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Diniz</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Ara&#xFA;jo</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Pita</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Dantas</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Ramalho</surname>
              <given-names>JA</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>The controvertible role of kava (Piper methysticum G. Foster) an anxiolytic herb, on toxic hepatitis</article-title>
          <source>Rev Bras Farmacogn</source>
          <year>2007</year>
          <volume>17</volume>
          <issue>3</issue>
          <fpage>448</fpage>
          <lpage>454</lpage>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Carvalho</surname>
              <given-names>RJ</given-names>
              <suffix>Filho</suffix>
            </name>
            <name>
              <surname>Khoury-Siyoufi</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Kemp</surname>
              <given-names>VL</given-names>
            </name>
          </person-group>
          <chapter-title xml:lang="pt">Les&#xF5;es hep&#xE1;ticas induzidas por drogas</chapter-title>
          <person-group person-group-type="author">
            <name>
              <surname>Miszputen</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <source xml:lang="pt">Guias de medicina ambulatorial e hospitalar da UNIFESP-Escola Paulista de Medicina</source>
          <edition>2a</edition>
          <publisher-loc>S&#xE3;o Paulo</publisher-loc>
          <publisher-name>Manole</publisher-name>
          <year>2007</year>
          <fpage>155</fpage>
          <lpage>170</lpage>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cordeiro</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Sacramento</surname>
              <given-names>LV</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Intera&#xE7;&#xF5;es medicamentosas de fitoter&#xE1;picos e f&#xE1;rmacos: Hypericum perforatum e Piper methysticum</article-title>
          <source>Rev Bras Farmacogn</source>
          <year>2005</year>
          <volume>15</volume>
          <issue>3</issue>
          <fpage>272</fpage>
          <lpage>278</lpage>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yellapu</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Mittal</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Grewal</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fiel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schiano</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Acute liver failure caused by &#x2018;fat burners&#x2019; and dietary supplements: a case report and literature review</article-title>
          <source>Can J Gastroenterol</source>
          <year>2011</year>
          <volume>25</volume>
          <issue>3</issue>
          <fpage>157</fpage>
          <lpage>160</lpage>
          <pub-id pub-id-type="pmid">21499580</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kennedy</surname>
              <given-names>DO</given-names>
            </name>
            <name>
              <surname>Wightman</surname>
              <given-names>EL</given-names>
            </name>
          </person-group>
          <article-title>Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function</article-title>
          <source>Adv Nutr</source>
          <year>2011</year>
          <volume>2</volume>
          <issue>1</issue>
          <fpage>32</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">22211188</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Schiano</surname>
              <given-names>TD</given-names>
            </name>
          </person-group>
          <article-title>Review article: drug hepatotoxicity</article-title>
          <source>Aliment Pharmacol Ther</source>
          <year>2007</year>
          <volume>25</volume>
          <issue>10</issue>
          <fpage>1135</fpage>
          <lpage>1151</lpage>
          <pub-id pub-id-type="pmid">17451560</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nahas</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sheikh</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Complementary and alternative medicine for the treatment of major depressive disorder</article-title>
          <source>Can Fam Physician</source>
          <year>2011</year>
          <volume>57</volume>
          <issue>6</issue>
          <fpage>659</fpage>
          <lpage>663</lpage>
          <pub-id pub-id-type="pmid">21673208</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rapaport</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Nierenberg</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Howland</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dording</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schettler</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Mischoulon</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>The treatment of minor depression with St. John&#x2019;s Wort or citalopram: failure to show benefit over placebo</article-title>
          <source>J Psychiatr Res</source>
          <year>2011</year>
          <volume>45</volume>
          <issue>7</issue>
          <fpage>931</fpage>
          <lpage>941</lpage>
          <pub-id pub-id-type="pmid">21632064</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Izzo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ernst</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Interactions between herbal medicines and prescribed drugs: an updated systematic review</article-title>
          <source>Drugs</source>
          <year>2009</year>
          <volume>69</volume>
          <issue>13</issue>
          <fpage>1777</fpage>
          <lpage>1798</lpage>
          <pub-id pub-id-type="pmid">19719333</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>An update on clinical drug interactions with the herbal antidepressant St. John&#x2019;s wort</article-title>
          <source>Can Drug Metab</source>
          <year>2008</year>
          <volume>9</volume>
          <issue>5</issue>
          <fpage>394</fpage>
          <lpage>409</lpage>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dom&#xED;nguez Jim&#xE9;nez</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Pleguezuelo Navarro</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Guiote Malpartida</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fraga Rivas</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Montero Alvarez</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Poyato Gonz&#xE1;lez</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Hepatotoxicity associated with Hypericum (St.John&#x2019;s wort)</article-title>
          <source>Gastroenterol Hepatol</source>
          <year>2007</year>
          <volume>30</volume>
          <issue>1</issue>
          <fpage>54</fpage>
          <lpage>55</lpage>
          <comment>Spanish</comment>
          <pub-id pub-id-type="pmid">17266882</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Noguchi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Reis</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Dias</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Epaminondas</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Azevedo</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Brito</surname>
              <given-names>MV</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">N&#xED;veis s&#xE9;ricos de aminotransferases, bilirrubinas e gama-glutamil transpeptidase ap&#xF3;s a administra&#xE7;&#xE3;o de &#xF3;leo de copa&#xED;ba em ratos</article-title>
          <source>Acta Cir Bras</source>
          <year>2002</year>
          <volume>17</volume>
          <issue>2</issue>
          <fpage>130</fpage>
          <lpage>134</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="TRen" article-type="translation" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Relato De Caso</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Hepatotoxicidade induzida por <italic>Hypericum perforatum</italic> com poss&#xED;vel associa&#xE7;&#xE3;o a copa&#xED;ba (<italic>Copaifera langsdorffii Desf</italic>): relato de caso</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Agollo</surname>
            <given-names>Marjorie Costa</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miszputen</surname>
            <given-names>Sender Jankiel</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Diament</surname>
            <given-names>Jayme</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
<sup>2</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff3"><label>1</label>Escola Paulista de Medicina, Universidade Federal de S&#xE3;o Paulo, S&#xE3;o Paulo, SP, Brasil.</aff>
      <aff id="aff4"><label>2</label>Hospital Israelita Albert Einstein, S&#xE3;o Paulo, SP, Brasil</aff>
      <author-notes>
        <corresp> Autor correspondente: Sender Jankiel Miszputen &#x2212; Escola Paulista de Medicina, Universidade Federal de S&#xE3;o Paulo, Disciplina de Gastroenterologia, Rua Botucat&#xFA;, 740 &#x2013; Vila Clementino &#x2013; CEP: 04023-900 &#x2212; S&#xE3;o Paulo, SP, Brasil &#x2013; Tel.: (11) 3825-1014 &#x2212; E-mail: <email>sender.miszputen@unifesp.br</email></corresp>
      </author-notes>
      <abstract>
        <p>Relatamos um caso de dano hep&#xE1;tico em paciente idosa ap&#xF3;s uso de produtos naturais &#xE0; base de <italic>Hypericum perforatum</italic> e copa&#xED;ba (<italic>Copaifera langsdorffii Desf</italic>). A hepatotoxicidade do <italic>Hypericum perforatum</italic> &#xE9; conhecida por relatos, mas a respeito da copa&#xED;ba, largamente usada como anti-inflamat&#xF3;rio, h&#xE1; apenas dados experimentais na literatura nacional. Essa apresenta&#xE7;&#xE3;o visou chamar a aten&#xE7;&#xE3;o para poss&#xED;vel efeito t&#xF3;xico dessa associa&#xE7;&#xE3;o, bem como para a recupera&#xE7;&#xE3;o cl&#xED;nica da paciente ap&#xF3;s interrup&#xE7;&#xE3;o de seu uso. H&#xE1; uma tend&#xEA;ncia de suspeitar sobre a a&#xE7;&#xE3;o de medicamentos para justificar a les&#xE3;o hep&#xE1;tica aguda n&#xE3;o viral, em raz&#xE3;o do grande n&#xFA;mero de f&#xE1;rmacos respons&#xE1;veis por hepatotoxicidade. A literatura tem publicado experimentos e relatos cl&#xED;nicos em que produtos fitoter&#xE1;picos, inclusive <italic>Hypericum perforatum</italic>, s&#xE3;o o agente causador dessa agress&#xE3;o, considerados in&#xF3;cuos e utilizados livremente. &#xC9; preciso lembrar que rea&#xE7;&#xF5;es adversas ocorrem tamb&#xE9;m com essas subst&#xE2;ncias, merecendo sua investiga&#xE7;&#xE3;o na obten&#xE7;&#xE3;o da anamnese, pela possibilidade de promoverem quadros graves de fal&#xEA;ncia hep&#xE1;tica.</p>
      </abstract>
      <kwd-group>
        <kwd>Doen&#xE7;a hep&#xE1;tica induzida por droga</kwd>
        <kwd><italic>Hypericum</italic>/efeitos adversos</kwd>
        <kwd>Medicamentos fitoter&#xE1;picos/efeitos adversos</kwd>
        <kwd>Relatos de casos</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <sec>
        <title>INTRODU&#xC7;&#xC3;O</title>
        <p>O f&#xED;gado metaboliza grande n&#xFA;mero de medicamentos, estando sujeito, desse modo, &#xE0; toxicidade induzida por eles. Sua hepatotoxicidade ocorre por a&#xE7;&#xE3;o direta, no caso de tuberculost&#xE1;ticos,<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup> estatinas, paracetamol,<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> ou &#xE9; idiossincr&#xE1;sica e inesperada, constituindo um problema cl&#xED;nico importante, que pode promover fal&#xEA;ncia hep&#xE1;tica, com consequ&#xEA;ncias fatais, ou requerer transplante de urg&#xEA;ncia.</p>
        <p>Acredita-se que a incid&#xEA;ncia seja subestimada, pois, usualmente, seu uso &#xE9; omitido. Manifesta-se de forma aguda ou cr&#xF4;nica, sendo a &#xFA;nica causa em at&#xE9; 30% das hepatites agudas, ou como colestase, esteatose ou fibrose. Est&#xE3;o identificadas mais de 900 subst&#xE2;ncias ex&#xF3;genas com potencial hepatot&#xF3;xico, bem como relatos com plantas herb&#xE1;ceas.<sup>(<xref rid="B3" ref-type="bibr">3</xref>)-<xref rid="B6" ref-type="bibr">6</xref>)</sup>
</p>
        <p>O homem utiliza extensa quantidade de alimentos, medicamentos e suplementos diet&#xE9;ticos derivados de plantas. Kennedy e Wightman<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup> revisaram os mecanismos de a&#xE7;&#xE3;o de diferentes fitoter&#xE1;picos: alcaloides (cafe&#xED;na e nicotina), terpenos (ginkgo, ginseng, valeriana e Melissa officinalis) e fen&#xF3;licos (curcumin, isoflavona e Hypericum perforatum).</p>
        <p>O quadro cl&#xED;nico agudo varia desde altera&#xE7;&#xF5;es laboratoriais reconhecidas ao acaso e sem nenhum sintoma, at&#xE9; n&#xE1;useas, v&#xF4;mitos, dor abdominal, icter&#xED;cia e insufici&#xEA;ncia hep&#xE1;tica aguda, podendo se sobrepor &#xE0; hepatopatias preexistentes. As les&#xF5;es s&#xE3;o classificadas em hepatocelular, colest&#xE1;tica, mista ou vascular. Inquerir sobre uso de drogas &#xE9; fundamental para o diagn&#xF3;stico, pois n&#xE3;o h&#xE1; exame padr&#xE3;o-ouro, marcador s&#xE9;rico espec&#xED;fico e nem perfil histol&#xF3;gico para identifica&#xE7;&#xE3;o daquela respons&#xE1;vel pela agress&#xE3;o hep&#xE1;tica.</p>
        <p>O tratamento consiste em suspender o produto suspeito, tomar medidas gerais, fazer repouso relativo e dieta branda, al&#xE9;m de monitorar a fun&#xE7;&#xE3;o hep&#xE1;tica, pelo risco de evolu&#xE7;&#xE3;o para insufici&#xEA;ncia hepatocelular.<sup>(<xref rid="B8" ref-type="bibr">8</xref>)</sup>
</p>
      </sec>
      <sec>
        <title>RELATO DE CASO</title>
        <p>Mulher, 79 anos, atendida por apresentar icter&#xED;cia h&#xE1; 1 m&#xEA;s. Hist&#xF3;ria pr&#xE9;via de hipotireoidismo. Em uso de Hypericum perforatum, copa&#xED;ba, levotiroxina, omega 3, glucosamina e condroitina. Ao exame f&#xED;sico, apresentava-se afebril, ict&#xE9;rica, normotensa e taquic&#xE1;rdica (100bpm). Abdome fl&#xE1;cido, indolor, sem visceromegalias ou sinais de hepatopatia cr&#xF4;nica. Exames laboratoriais evidenciaram altera&#xE7;&#xF5;es enzim&#xE1;ticas e hiperbilirrubinemia, com outros par&#xE2;metros preservados. As sorologias para hepatites virais e autoanticorpos foram negativas. Colangiorresson&#xE2;ncia sem altera&#xE7;&#xF5;es.</p>
        <p>O tratamento institu&#xED;do foi repouso e suspens&#xE3;o de todas as medica&#xE7;&#xF5;es, exceto a reposi&#xE7;&#xE3;o hormonal para a tireoidopatia</p>
        <p>Dentre os par&#xE2;metros laboratoriais inicialmente elevados, a ALT-TGP de 1.667U/L, ap&#xF3;s cerca de 7 semanas, caiu para 36U/L, e a AST-TGO de 1.599U/L para 30U/L. Recupera&#xE7;&#xE3;o semelhante foi observada nos n&#xED;veis de bilirrubina total, que passaram de 9,0mg/dL para 1,24mg/dL, em raz&#xE3;o da queda das taxas da fra&#xE7;&#xE3;o direta, de 8,3mg/dL para 0,73mg/dL.</p>
      </sec>
      <sec>
        <title>DISCUSS&#xC3;O</title>
        <p>O Hypericum perforatum, ou Erva de S&#xE3;o Jo&#xE3;o, &#xE9; largamente distribu&#xED;do em v&#xE1;rios pa&#xED;ses, com indica&#xE7;&#xE3;o para tratamento de depress&#xE3;o leve a moderada,<sup>(<xref rid="B9" ref-type="bibr">9</xref>)</sup> ansiedade, ins&#xF4;nia e dores nevr&#xE1;lgicas, tendo reconhecida atividade antiviral, antibacteriana e fotossensibilizadora. Sua a&#xE7;&#xE3;o antidepressiva n&#xE3;o &#xE9; consensual,<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup> mas, em alguns pa&#xED;ses, como na Alemanha, representa cerca de 25% do total de prescri&#xE7;&#xF5;es dessa classe de medicamento, estando acess&#xED;vel em farm&#xE1;cias de manipula&#xE7;&#xE3;o, de fitoter&#xE1;picos ou de produtos naturais.</p>
        <p>Agindo sobre o citocromo P450, pode reduzir os n&#xED;veis s&#xE9;ricos de alguns medicamentos ou aumentar seu clareamento.<sup>(<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B5" ref-type="bibr">5</xref>)</sup> A intera&#xE7;&#xE3;o com outros f&#xE1;rmacos favorece seus efeitos adversos,<sup>(<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>)</sup> sendo a hepatotoxicidade j&#xE1; descrita.<sup>(<xref rid="B13" ref-type="bibr">13</xref>)</sup>
</p>
        <p>No caso apresentado, foi imperativo pesquisar outras causas de doen&#xE7;a hep&#xE1;tica aguda: sorologias para v&#xED;rus das hepatites A, B e C; autoimunidade, apesar da idade, avaliada pela dosagem inicial das globulinas s&#xE9;ricas; e m&#xE9;todos de imagem, particularmente colangiorresson&#xE2;ncia, para excluir anormalidades nas vias biliares intra e extra-hep&#xE1;ticas.</p>
        <p>A evolu&#xE7;&#xE3;o laboratorial da paciente mostrou diminui&#xE7;&#xE3;o progressiva das enzimas e da bilirrubina, ap&#xF3;s a suspens&#xE3;o das drogas suspeitas da hepatotoxcidade, com sua normaliza&#xE7;&#xE3;o sem outras intercorr&#xEA;ncias.</p>
        <p>O segundo produto herb&#xE1;ceo, a copa&#xED;ba, um &#xF3;leo-resina extra&#xED;do do tronco da Copaifera ssp., muito utilizado como anti-inflamat&#xF3;rio nos Estados das Regi&#xF5;es Norte/Nordeste do Brasil, tem seu efeito hepatot&#xF3;xico discut&#xED;vel,<sup>(<xref rid="B14" ref-type="bibr">14</xref>)</sup> n&#xE3;o se excluindo a possibilidade de sua participa&#xE7;&#xE3;o, em conjunto com o outro fitoter&#xE1;pico, no desencadeamento da hepatite aguda medicamentosa descrita.</p>
      </sec>
      <sec>
        <title>CONCLUS&#xC3;O</title>
        <p>Esta apresenta&#xE7;&#xE3;o procurou refor&#xE7;ar a import&#xE2;ncia de uma hist&#xF3;ria cl&#xED;nica detalhada, com especial aten&#xE7;&#xE3;o &#xE0;s medica&#xE7;&#xF5;es utilizadas pelos doentes. A inocuidade aparente de produtos naturais permite seu livre consumo, sem consider&#xE1;-los de risco para o desenvolvimento de doen&#xE7;as. O mesmo motivo faz o doente omitir essa informa&#xE7;&#xE3;o em sua hist&#xF3;ria cl&#xED;nica. Cabe ao m&#xE9;dico questionar sobre todas as drogas em uso atual ou recente, investigar sobre suas caracter&#xED;sticas de toxicidade, especialmente quando da intera&#xE7;&#xE3;o com outros medicamentos, pois ter&#xE1; um maior conjunto de dados para a hip&#xF3;tese diagn&#xF3;stica e sua diferencia&#xE7;&#xE3;o. O que &#xE9; v&#xE1;lido para a explora&#xE7;&#xE3;o de qualquer doen&#xE7;a &#xE9; particularmente importante nos casos das hepatopatias, j&#xE1; que essa v&#xED;scera mostra especial sensibilidade na resposta &#xE0; a&#xE7;&#xE3;o qu&#xED;mica de determinados f&#xE1;rmacos. Particularmente no presente caso, deu-se &#xEA;nfase ao uso da copa&#xED;ba associado ao Hypericum.</p>
      </sec>
    </body>
  </sub-article>
</article>
</pmc-articleset>
